EGFR and prostate carcinoma: We identified the regulatory mechanisms of miR-203 interaction with EGFR signaling, and we defined the roles of the miR-203 regulatory pathway in Ras-activated prostate cancer metastasis and tyrosine kinase inhibitors (TKIs) resistance processes.